Interestingly, in a similar approach, adenoviruses coated in a bioengineered cell membrane expressing PD-1 to target PD-L1 were shown to effectively reactivate exhausted tumor-specific CD8+ T cells, inhibit tumor cell proliferation, and improve the anti-tumor efficacy in vitro and in vivo [63]. The gene discussed is PDCD1; the disease is neoplasm.